# Lucy Burr
**Source**: https://about.uq.edu.au/experts/3504
**Parent**: https://about.uq.edu.au/experts/934
Associate Professor
# Lucy Burr
Email:
: [l.burr@uq.edu.au](mailto:l.burr@uq.edu.au)
## Positions
ATH - Associate Professor
: Mater Research Institute-UQ
: Faculty of Health, Medicine and Behavioural Sciences
### Background
A/Prof Lucy Burr is an experienced respiratory physician, training supervisor and clinical trials researcher at Mater Health and Mater Research – University of Queensland (UQ). She has a PhD (2017) in bronchiectasis microbiology and is an Associate Professor at the School of Medicine, UQ. She is the Director of Respiratory, Sleep and Cystic Fibrosis medicine at the Mater Hospital, Brisbane.
As well as directing the respiratory clinical service at the Mater, Lucy has an active role in teaching both specialist trainees and medical students. She is a RACP college supervisor and trains one advanced trainee and four basic trainees per year. She directly supervises four medical students in her clinical team per year. Lucy is also currently supervising 5 PhD students, researching diverse fields such as glucose control in cystic fibrosis, asthma, fatigue, IL-22 and the effect of sleep on social cognition.
Lucy is recognised nationally for her clinical work on respiratory infections. She is the chair of the Acute and Critical Care panel for the National COVID-19 clinical evidence taskforce and a member of the guideline leadership group. Additionally, she is the recent chair (2020-2022) of the expert reference group on COVID-19 for the Royal Australasian College of Physicians. She is a recent (2019- 2021) convenor of the respiratory infectious disease special interest group of the Thoracic Society of Australia and New Zealand, the Queensland TSANZ branch president and past president (2017-2020), a recent board director of the TSANZ national body and current Chair of the Australian Bronchiectasis Consortium. Lucy is currently serving on the TSANZ annual scientific meeting and World Bronchiectasis conference steering committees. She is recognised internationally for her work on Cystic Fibrosis (top 1.8% expertscape February 2024) and Bronchiectasis (top 2.2% expertscape February 2024) and has published in high impact clinical journals including the New England Journal of Medicine and the Lancet Respiratory Medicine, across a range of respiratory and infectious disease subjects, with >1500 citations in the past 5 years.
In addition to her clinical work, Lucy is the custodian and manager of the David Serisier Research biobank at Mater Research, a clinical repository of human samples from patients living with respiratory diseases. Lucy is also an experienced principal investigator on many pharmaceutical studies ranging from phase 1b to phase 4 studies investigating therapeutics for CF, IPF, COPD, COVID, influenza pulmonary hypertension and bronchiectasis. She has designed and lead non-pharmaceutical interventional studies investigating the role of macrolide in modulating inflammation in healthy adults. She is the group leader of the respiratory clinical trials unit at Mater Research, and the program lead for the chronic and integrated care program at Mater Research.
Lucy has a proven track record in collaborative and translational research. She is currently a consultant on 2 peer reviewed external grants totalling $1,306,000, including one involving biobanked samples, and is a chief investigator on a 2021 Ideas grant and a 2021 MRFF grant totalling more than $3 million dollars.
Read more
Read less
### Availability
Associate Professor Lucy Burr is:
: Available for supervision
### Fields of research
[Biological Sciences](https://about.uq.edu.au/experts/search?research-field=4771)
[Biomedical and Clinical Sciences](https://about.uq.edu.au/experts/search?research-field=4760)
[Cardiovascular medicine and haematology](https://about.uq.edu.au/experts/search?research-field=4899)
[Clinical sciences](https://about.uq.edu.au/experts/search?research-field=4979)
[Infectious diseases](https://about.uq.edu.au/experts/search?research-field=6765)
[Microbiology](https://about.uq.edu.au/experts/search?research-field=4957)
[Respiratory diseases](https://about.uq.edu.au/experts/search?research-field=6366)
### Qualifications
- Bachelor (Honours) of Medical Sciences, King's College London
- Bachelor of Medicine and Surgery and Medical Science, King's College London
- Doctor of Philosophy of Respiratory Diseases, The University of Queensland
- Diploma of Leadership and Management, Mater Education
- Fellow, Royal Australasian College of Physicians, Royal Australasian College of Physicians
- Fellow, Thoracic Society of Australia & New Zealand, Thoracic Society of Australia & New Zealand
[Search Professor Lucy Burr’s works on UQ eSpace](http://espace.library.uq.edu.au/list/author_id/82149)
[All
(88)](https://about.uq.edu.au/experts-publication/3504/all)
[Journal Article
(52)](https://about.uq.edu.au/experts-publication/3504/4748)
[Other Outputs
(1)](https://about.uq.edu.au/experts-publication/3504/4749)
[Conference Publication
(35)](https://about.uq.edu.au/experts-publication/3504/4751)
2025
Journal Article
##### Advancing bronchiectasis care in adult Indigenous people - An Australian rural and remote perspective
Heraganahally, Subash S., Howarth, Timothy, Chen, Winnie, Ford, Payi L., Lee, Annemarie L., Jayaram, Lata, Burr, Lucy, Markey, Peter and Barry, Simone (2025). Advancing bronchiectasis care in adult Indigenous people - An Australian rural and remote perspective. Current Pulmonology Reports, 14 (1) 29, 1-18. doi: 10.1007/s13665-025-00395-y
[Advancing bronchiectasis care in adult Indigenous people - An Australian rural and remote perspective](https://espace.library.uq.edu.au/view/UQ:82a5e12)
2025
Journal Article
##### Vaccine-induced and hybrid immunity against SARS-CoV-2 variants of concern in two cohorts in Queensland, Australia (2021-2022)
Parry, Rhys H., Shang, Yingjun, Sng, Julian D. J., McMillan, Christopher L. D., Modhiran, Naphak, Amarilla, Alberto A., Isaacs, Ariel, Liang, Benjamin, Muller, David A., Rawle, Daniel J., Suhrbier, Andreas, Anderson, Stevie, Kelly, Samuel, Watterson, Daniel, Burr, Lucy D. and Khromykh, Alexander A. (2025). Vaccine-induced and hybrid immunity against SARS-CoV-2 variants of concern in two cohorts in Queensland, Australia (2021-2022). Journal of Medical Virology, 97 (10) e70642, 1-15. doi: 10.1002/jmv.70642
[Vaccine-induced and hybrid immunity against SARS-CoV-2 variants of concern in two cohorts in Queensland, Australia (2021-2022)](https://espace.library.uq.edu.au/view/UQ:e29725b)
2025
Journal Article
##### Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study
Sibila, Oriol, Stobo, Jamie, Perea, Lidia, Gao, Yong-Hua, Xu, Jin-Fu, Lind, Holly, Viligorska, Kateryna, Spinou, Arietta, Polverino, Eva, Ringshausen, Felix C, Vendrell, Montserrat, Burgel, Pierre-Régis, Haworth, Charles S, Loebinger, Michael R, Lorent, Natalie, Dhar, Raja, Choi, Hayoung, Chotirmall, Sanjay H, De Soyza, Anthony, Hurst, John R, Brown, Jeremy S, van der Eerden, Menno, Kauppi, Paula, Johnson, Emma D, Mendez, Raul, Dimakou, Katerina, Bossios, Apostolos, Torres, Antoni, Blasi, Francesco ... Chalmers, James D (2025). Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study. The Lancet Respiratory Medicine, 13 (10), 911-920. doi: 10.1016/s2213-2600(25)00160-2
[Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study](https://espace.library.uq.edu.au/view/UQ:c26c093)
2025
Journal Article
##### Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials
Keating, Claire, Yonker, Lael M, Vermeulen, François, Prais, Dario, Linnemann, Rachel W, Trimble, Aaron, Kotsimbos, Tom, Mermis, Joel, Braun, Andrew T, O'Carroll, Mark, Sutharsan, Sivagurunathan, Ramsey, Bonnie, Mall, Marcus A, Taylor-Cousar, Jennifer L, McKone, Edward F, Tullis, Elizabeth, Floreth, Tim, Michelson, Peter, Sosnay, Patrick R, Nair, Nitin, Zahigian, Rachel, Martin, Hannah, Ahluwalia, Neil, Lam, Anna, Horsley, Alexander, Krick, Stefanie, McCoy, Karen, Goss, Christopher, Weiner, Daniel ... O'Carroll, Mark (2025). Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials. The Lancet Respiratory Medicine, 13 (3), 256-271. doi: 10.1016/S2213-2600(24)00411-9
[Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials](https://espace.library.uq.edu.au/view/UQ:217417e)
2025
Journal Article
##### Polysomnographic (PSG) Characteristics of Sleep Behaviour in Parkinson's Disease: A Brief Report
Feigl, Beatrix, Gnyawali, Subodh, Burr, Lucy D., Duggan, Glenice and Zele, Andrew J. (2025). Polysomnographic (PSG) Characteristics of Sleep Behaviour in Parkinson's Disease: A Brief Report. Journal of Sleep Research, e70108. doi: 10.1111/jsr.70108
[Polysomnographic (PSG) Characteristics of Sleep Behaviour in Parkinson's Disease: A Brief Report](https://espace.library.uq.edu.au/view/UQ:e67e866)
2025
Journal Article
##### Turning the tide on bronchiectasis in adult Aboriginal Australians: from neglect to action
Heraganahally, Subash S., Howarth, Timothy, Heraganahally, Sanjana, Duncan, Dayna, Chen, Winnie, Ford, Payi L., Sorger, Lisa, Barry, Simone and Burr, Lucy (2025). Turning the tide on bronchiectasis in adult Aboriginal Australians: from neglect to action. Internal Medicine Journal, 55 (9), 1578-1582. doi: 10.1111/imj.70116
[Turning the tide on bronchiectasis in adult Aboriginal Australians: from neglect to action](https://espace.library.uq.edu.au/view/UQ:3c310f8)
2024
Journal Article
##### Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis Registry
Webb, Elizabeth M., Holland, Anne E., Chang, Anne B., Burr, Lucy, Holmes-Liew, Chien-Li, King, Paul T., Middleton, Peter G., Morgan, Lucy, Thomson, Rachel M., Wong, Conroy and Lee, Annemarie L. (2024). Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis Registry. Respiratory Medicine, 233 107777, 1-8. doi: 10.1016/j.rmed.2024.107777
[Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis Registry](https://espace.library.uq.edu.au/view/UQ:47c08d4)
2024
Journal Article
##### Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function
Sinclair, Jane E., Vedelago, Courtney, Ryan, Feargal J., Carney, Meagan, Redd, Meredith A., Lynn, Miriam A., Grubor-Bauk, Branka, Cao, Yuanzhao, Henders, Anjali K., Chew, Keng Yih, Gilroy, Deborah, Greaves, Kim, Labzin, Larisa, Ziser, Laura, Ronacher, Katharina, Wallace, Leanne M., Zhang, Yiwen, Macauslane, Kyle, Ellis, Daniel J., Rao, Sudha, Burr, Lucy, Bain, Amanda, Karawita, Anjana, Schulz, Benjamin L., Li, Junrong, Lynn, David J., Palpant, Nathan, Wuethrich, Alain, Trau, Matt and Short, Kirsty R. (2024). Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function. Nature Microbiology, 9 (12), 1-13. doi: 10.1038/s41564-024-01838-z
[Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function](https://espace.library.uq.edu.au/view/UQ:0542947)
2024
Journal Article
##### Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro
Goeteyn, Ellen, Taylor, Steven L., Dicker, Alison, Bollé, Laura, Wauters, Merel, Joossens, Marie, Van Braeckel, Eva, Simpson, Jodie L., Burr, Lucy, Chalmers, James D., Rogers, Geraint B. and Crabbé, Aurélie (2024). Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro. Respiratory research, 25 (1) 368, 1-14. doi: 10.1186/s12931-024-02983-z
[Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro](https://espace.library.uq.edu.au/view/UQ:dfb393a)
2024
Conference Publication
##### Noxturnal cRIP: An alternative to AASM recommended flow sensors in analysis of respiratory events in polysomnography
Eriksson, N. and Burr, L. (2024). Noxturnal cRIP: An alternative to AASM recommended flow sensors in analysis of respiratory events in polysomnography. Sleep DownUnder 2024, Gold Coast, QLD Australia, 16-19 October 2024. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/sleepadvances/zpae070.116
[Noxturnal cRIP: An alternative to AASM recommended flow sensors in analysis of respiratory events in polysomnography](https://espace.library.uq.edu.au/view/UQ:6a324ec)
2024
Conference Publication
##### Highly symptomatic patients have an increased risk of exacerbations and benefit from long-term macrolide treatment in Bronchiectasis
Sibila Vidal, Oriol, Stobo, Jamie, Perea, Lidia, Gao, Yong-Hua, Spinou, Arietta, Polverino, Eva, Ringshausen, Felix, Vendrell, Montserrat, Burgel, Pierre-Régis, Haworth, Charles S., Loebinger, Michael R., Lorent, Natalie, Dhar, Raja, Choi, Hayoung, Chotirmall, Sanjay, Hurst, John R., Brown, Jeremy S., Mcdonnell, Melissa, Van Der Eerden, Menno, Kauppi, Paula, Johnson, Emma D., Menendez, Rosario, Dimakou, Katerina, Bossios, Apostolos, Crichton, Megan L., Torres, Antoni, Welte, Tobias, Blasi, Francesco, Shteinberg, Michal ... Chalmers, James D. (2024). Highly symptomatic patients have an increased risk of exacerbations and benefit from long-term macrolide treatment in Bronchiectasis. ERS Congress 2024, Vienna, Austria, 7–11 September 2024. Sheffield, United Kingdom: European Respiratory Society. doi: 10.1183/13993003.congress-2024.pa2375
[Highly symptomatic patients have an increased risk of exacerbations and benefit from long-term macrolide treatment in Bronchiectasis](https://espace.library.uq.edu.au/view/UQ:1a2a9e7)
2024
Conference Publication
##### Age-dependent dysregulation of the UPR in colonic epithelium: Implications for mucosal integrity
Illankoon, Thishan, Wong, Kuan Yau, Sajiir, Haressh, Mueller, Alexandra, Amiss, Anna, Begun, Jakob, Giri, Rabina, Burr, Lucy and Hasnain, Sumaira (2024). Age-dependent dysregulation of the UPR in colonic epithelium: Implications for mucosal integrity. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.
[Age-dependent dysregulation of the UPR in colonic epithelium: Implications for mucosal integrity](https://espace.library.uq.edu.au/view/UQ:93b9abd)
2024
Journal Article
##### Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing
Pham, Amy, Tan, Kellynn K. Y., Ledger, Emma L., Smith, Daniel J., Reid, David W., Burr, Lucy, Chambers, Daniel C. and Wells, Timothy J. (2024). Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing. Frontiers in Cellular and Infection Microbiology, 14 1426773, 1426773. doi: 10.3389/fcimb.2024.1426773
[Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing](https://espace.library.uq.edu.au/view/UQ:59d240c)
2024
Conference Publication
##### Barriers to the annual OGTT: the patient perspective
Keating, Rebecca and Burr, Lucy (2024). Barriers to the annual OGTT: the patient perspective. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2-4 August 2024. Richmond, VIC Australia: John Wiley & Sons.
[Barriers to the annual OGTT: the patient perspective](https://espace.library.uq.edu.au/view/UQ:f06d518)
2024
Conference Publication
##### Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study
Mattison, Graeme, Keating, Rebecca, McWhinney, Brett, Connors, Shannon, Swenson, Rebecca, Evans, Ieuan, Burke, Andrew and Burr, Lucy (2024). Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2–4 August 2024. Richmond, VIC Australia: John Wiley & Sons.
[Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study](https://espace.library.uq.edu.au/view/UQ:12118c6)
2024
Conference Publication
##### Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in Queensland
Wood, Michelle, Smith, Iain, Hiscock, Keirran, Smith, Daniel, Keating, Rebecca, Burr, Lucy, Tay, George, Zimmerman, Maureen, Feather, Iain, Cobb, Robyn, Moore, Vanessa, Evans, Ieuan, Reid, David, Masel, Philip, Mackintosh, John and Henderson, Daniel (2024). Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in Queensland. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2-4 August 2024. Richmond, VIC Australia: John Wiley & Sons.
[Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in Queensland](https://espace.library.uq.edu.au/view/UQ:e9051b0)
2024
Conference Publication
##### Management of incretins: the future of glucose management in cystic fibrosis
Keating, Rebecca and Burr, Lucy (2024). Management of incretins: the future of glucose management in cystic fibrosis. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2-4 August 2024. Richmond, VIC Australia: John Wiley & Sons.
[Management of incretins: the future of glucose management in cystic fibrosis](https://espace.library.uq.edu.au/view/UQ:cc73b08)
2024
Journal Article
##### Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial
Bennett, Chijioke, Woo, Wayne, Bloch, Mark, Cheung, King, Griffin, Paul (Novavax 2019nCoV-311 Study Group), Mohan, Rahul, Deshmukh, Sachin, Arya, Mark, Cumming, Oscar, Neville, A Munro, McCallum Pardey, Toni G, Plested, Joyce S, Cloney-Clark, Shane, Zhu, Mingzhu, Kalkeri, Raj, Patel, Nita, Marcheschi, Alex, Swan, Jennifer, Smith, Gale, Cho, Iksung, Glenn, Gregory M, Walker, Robert, Mallory, Raburn M, Anderson, Anna, Ang, Mary, Barnes, Timothy, Bassin, Michelle, Bessey, Kate, Bowler, Simon ... Novavax 2019nCoV-311 Study Group (2024). Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial. The Lancet Infectious Diseases, 24 (6), 581-593. doi: 10.1016/S1473-3099(24)00077-X
[Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial](https://espace.library.uq.edu.au/view/UQ:e538f09)
2024
Journal Article
##### Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis
Sajiir, Haressh, Wong, Kuan Yau, Müller, Alexandra, Keshvari, Sahar, Burr, Lucy, Aiello, Elena, Mezza, Teresa, Giaccari, Andrea, Sebastiani, Guido, Dotta, Francesco, Ramm, Grant A., Macdonald, Graeme A., McGuckin, Michael A., Prins, Johannes B. and Hasnain, Sumaira Z. (2024). Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis. Nature Communications, 15 (1) 4527, 1-12. doi: 10.1038/s41467-024-48320-2
[Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis](https://espace.library.uq.edu.au/view/UQ:69bca37)
2024
Journal Article
##### Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis
Sajiir, Haressh, Keshvari, Sahar, Wong, Kuan Yau, Borg, Danielle J., Steyn, Frederik J., Fercher, Christian, Taylor, Karin, Taylor, Breten, Barnard, Ross T., Müller, Alexandra, Moniruzzaman, Md, Miller, Gregory, Wang, Ran, Fotheringham, Amelia, Schreiber, Veronika, Sheng, Yong Hua, Hancock, Janelle Louise, Loo, Dorothy, Burr, Lucy, Huynh, Tony, Lockett, Jack, Ramm, Grant A., Macdonald, Graeme A., Prins, Johannes B., McGuckin, Michael A. and Hasnain, Sumaira Z. (2024). Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis. Nature Communications, 15 (1) 4528, 1-13. doi: 10.1038/s41467-024-48317-x
[Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis](https://espace.library.uq.edu.au/view/UQ:d6b6570)
### Current funding
- 2026 - 2031
Reducing ageism in healthcare
ARC Linkage Projects
[Open grant](https://about.uq.edu.au/experts/project/70686)
- 2022 - 2026
Predicting and preparing for the unfolding evolution of SARS-CoV-2
NHMRC IDEAS Grants
[Open grant](https://about.uq.edu.au/experts/project/51628)
### Availability
Associate Professor Lucy Burr is:
: Available for supervision
Looking for a supervisor? Read our advice on [how to choose a supervisor](https://study.uq.edu.au/study-options/phd-mphil-professional-doctorate/how-to-choose-a-supervisor).
### Supervision history
#### Current supervision
- Doctor Philosophy
##### Achieving Remission in Asthma
Principal Advisor
Other advisors:
[Honorary Professor Sumaira Hasnain](https://about.uq.edu.au/experts/8835)
- Doctor Philosophy
##### Decline of Unfolded Protein Response with Age Increases Susceptibility to Infection and Inflammation
Associate Advisor
Other advisors:
[Honorary Professor Sumaira Hasnain](https://about.uq.edu.au/experts/8835)
- Doctor Philosophy
##### The contribution of neutrophils to the immunopathology of severe viral bronchiolitis, asthma and bronchiectasis
Associate Advisor
- Doctor Philosophy
##### Helping children to flourish by improving sleep after childhood traumatic brain injury
Associate Advisor
Other advisors:
[Professor Stewart Trost](https://about.uq.edu.au/experts/934), [Dr Lori Delaney](https://about.uq.edu.au/experts/38829), [Professor Karen Barlow](https://about.uq.edu.au/experts/19570)
#### Completed supervision
- 2025
Doctor Philosophy
##### [AN INVESTIGATION INTO THE FACTORS INFLUENCING GLUCOSE CONTROL IN CYSTIC FIBROSIS.](https://espace.library.uq.edu.au/view/UQ:01475c2)
Principal Advisor
- 2023
Doctor Philosophy
##### [Sleep and Psychological Function: The Relationship Between Sleep with Stress, Aggression, and Episodic Foresight](https://espace.library.uq.edu.au/view/UQ:fdacb76)
Associate Advisor
Other advisors:
[Dr Sarah Grainger](https://about.uq.edu.au/experts/19779), [Professor Julie Henry](https://about.uq.edu.au/experts/2589)
### Enquiries
For media enquiries about Associate Professor Lucy Burr's areas of expertise, story ideas and help finding experts, contact our Media team:
[communications@uq.edu.au](mailto:communications@uq.edu.au)
## External profiles
- [ORCID](https://orcid.org/0000-0003-4010-3787)
- [ResearcherID](https://www.webofscience.com/wos/author/record/F-8296-2015)
- [Scopus](https://www.scopus.com/authid/detail.uri?authorId=56241356800)
- [Google Scholar](https://scholar.google.com.au/citations?user= )
## Personal links
- [Personal profile](http://www.materonline.org.au/specialist/respiratory-and-sleep-medicine/dr-lucy-burr)
- [Google Scholar Link](https://scholar.google.com.au/citations?hl=en&view_op=list_works&gmla=AJsN-F5zBXAUMtwHS9NX0aE1VBfj1o2ilJH8mcpFEqSq09OvG432l44L9gx8alITZ-NxTyXRzU5LqUd0TI5tAre-WdKjOVIs3Q&user=qx6v6IYAAAAJ)
- [Scopus Author ID](http://www.scopus.com/inward/authorDetails.url?authorID=56241356800&partnerID=MN8TOARS)
Log in to Academic Portal to update your profile
[Update my profile](https://academicportal.app.uq.edu.au/profile/)